Rossari Biotech plans to acquire Tristar Intermediates for Rs 120 cr
Products

Rossari Biotech plans to acquire Tristar Intermediates for Rs 120 cr

Rossari Biotech Limited, a specialty chemicals manufacturer, told the media that it has agreed to acquire Tristar Intermediates Pvt Ltd for Rs 120 crore in multiple tranches.

Rossari Biotech said that the acquisition will occur in multiple tranches.

It will acquire a 76% equity stake of Tristar by September this year, as part of the first tranche, and the remaining will be acquired by the financial ending March 31, 2025.

As part of its inorganic growth plan, the acquisition is in line with Rossari Biotech's strategy to set its place in specialty chemicals manufacturing.

Tristar allows synergies in manufacturing and marketing that can be highly valued accretive in the long run.

Tristar is involved in the manufacture and trade of organic and inorganic chemicals and was incorporated on September 1, 1997.

It has three manufacturing plants with a capability of 15,000 million tonnes per annum (MTPA).

It had registered a turnover of Rs 110.5 crore in the last financial year 2020-21 against Rs 95.2 crore in the prior fiscal year.

Rossari Biotech announced last month that it will buy Unitop Chemicals Private for Rs 421 crore in an all-cash deal.

Marking its first initial public offering (IPO) since India went into a lockdown in late March to manage the pandemic, Rossari went public in July last year.

Before that, the company had raised Rs 100 crore by allocating shares to eight institutional investors in a pre-initial public offering (IPO) round.

Image Source

Rossari Biotech Limited, a specialty chemicals manufacturer, told the media that it has agreed to acquire Tristar Intermediates Pvt Ltd for Rs 120 crore in multiple tranches. Rossari Biotech said that the acquisition will occur in multiple tranches. It will acquire a 76% equity stake of Tristar by September this year, as part of the first tranche, and the remaining will be acquired by the financial ending March 31, 2025. As part of its inorganic growth plan, the acquisition is in line with Rossari Biotech's strategy to set its place in specialty chemicals manufacturing. Tristar allows synergies in manufacturing and marketing that can be highly valued accretive in the long run. Tristar is involved in the manufacture and trade of organic and inorganic chemicals and was incorporated on September 1, 1997. It has three manufacturing plants with a capability of 15,000 million tonnes per annum (MTPA). It had registered a turnover of Rs 110.5 crore in the last financial year 2020-21 against Rs 95.2 crore in the prior fiscal year. Rossari Biotech announced last month that it will buy Unitop Chemicals Private for Rs 421 crore in an all-cash deal. Marking its first initial public offering (IPO) since India went into a lockdown in late March to manage the pandemic, Rossari went public in July last year. Before that, the company had raised Rs 100 crore by allocating shares to eight institutional investors in a pre-initial public offering (IPO) round. Image Source

Next Story
Infrastructure Urban

CBI arrests NHIDCL official in Rs 1 Mn bribery case and seizes Rs 20.62 Mn

The Central Bureau of Investigation (CBI) has arrested Maisnam Riten Kumar Singh, Executive Director and Regional Officer of the National Highways and Infrastructure Development Corporation Limited (NHIDCL), Guwahati, for allegedly accepting a bribe of ₹10 lakh from a private individual in connection with a highway project in Assam.According to a  , the arrest followed a trap laid on October 14, after the agency received source-based information regarding the alleged demand for illegal gratification. Singh was reportedly caught red-handed while accepting the money from a representative of a..

Next Story
Infrastructure Transport

IRFC Posts Record Profit as Diversification Boosts Growth

Indian Railway Finance Corporation (IRFC), a Navratna CPSE under the Ministry of Railways, has reported its highest-ever profit after tax (PAT) driven by strategic diversification and improved margins. For the quarter ended 30 September 2025, IRFC posted a PAT of Rs 17,769.8 million, a 10.19 per cent increase from Rs 16,126.5 million in the same quarter last year. For the half-year, PAT rose 10.45 per cent year-on-year to Rs 35,226.7 million. Total income stood at Rs 63,719.1 million for Q2 and Rs 132,901.5 million for the half-year, supported by effective liability management and steady asse..

Next Story
Infrastructure Transport

KMEW to launch River Pearl Cruise linking Statue of Unity & Omkareshwar

Knowledge Marine & Engineering Works Limited (KMEW) has received a Letter of Acceptance (LoA) from the Madhya Pradesh Tourism Board (MPTB) to build and operate a luxury cruise between Kukshi in Madhya Pradesh and the Statue of Unity in Gujarat along the Narmada River. The 20-year project covers a 135-km stretch and marks KMEW’s official entry into India’s maritime tourism sector. The LoA was formally presented at the Madhya Pradesh Travel Mart 2025 by Hon’ble Union Minister of Culture Gajendra Singh Shekhawat, Chief Minister Dr. Mohan Yadav, and Minister of State for Tourism Dharmen..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?